Product Wiki · Recalls · EU Safety Gate (RAPEX)

X-TREME SILVER ANTI FRIZZ MASK — recall SR/01663/25

EU Safety Gate (RAPEX) · France · 2025-05-02 · Serious risk

Machine-translated with AI — the facts come from the issuing authority’s own notice (linked on this page); this language version was translated automatically by an AI model and is not reviewed. The original-language notice is authoritative. How we use AI →
Agency
EU Safety Gate (RAPEX)
Recall identifier
SR/01663/25
Date of alert
2025-05-02
Country / jurisdiction
France
Risk level
Serious risk
Risk type
Chemical
Brand
MOOD COSMETICS
Product category
Cosmetics
Product type
Hair cream
Barcode (EAN/GTIN)
7908433413547
Reported risk: Le produit contient du formaldéhyde (valeur mesurée : 0,5 %). Le formaldéhyde est un sensibilisant cutané et peut déclencher des réactions allergiques et peut provoquer le cancer. Le produit n'est pas conforme au règlement sur les produits cosmétiques.
Action taken by the authority
Type of economic operator taking notified measure
Manufacturer
Category of measure
Withdrawal of the product from the market
Date of entry into force
04/04/2025
Machine translation. This page was translated automatically from the English record we hold of the issuing authority’s notice. The English original is shown below and the authority’s own notice is linked above — both take precedence over this translation.

Product Name (original English): X-TREME SILVER ANTI FRIZZ MASK

Risk Description (original English): The product contains formaldehyde (measured value: 0.5 %). Formaldehyde is a skin sensitiser and can trigger allergic reactions and may cause cancer.

Primary source: https://ec.europa.eu/safety-gate-alerts/screen/webReport/alertDetail/10094145

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.